These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23404300)

  • 41. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.
    Gerstein HC; Miller ME; Ismail-Beigi F; Largay J; McDonald C; Lochnan HA; Booth GL;
    Lancet; 2014 Nov; 384(9958):1936-41. PubMed ID: 25088437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers.
    Sundberg F; deBeaufort C; Krogvold L; Patton S; Piloya T; Smart C; Van Name M; Weissberg-Benchell J; Silva J; diMeglio LA
    Pediatr Diabetes; 2022 Dec; 23(8):1496-1511. PubMed ID: 36537520
    [No Abstract]   [Full Text] [Related]  

  • 43. Systems Chronotherapeutics.
    Ballesta A; Innominato PF; Dallmann R; Rand DA; Lévi FA
    Pharmacol Rev; 2017 Apr; 69(2):161-199. PubMed ID: 28351863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Randomized Controlled Study of an Insulin Dosing Application That Uses Recognition and Meal Bolus Estimations.
    Pańkowska E; Ładyżyński P; Foltyński P; Mazurczak K
    J Diabetes Sci Technol; 2017 Jan; 11(1):43-49. PubMed ID: 28264177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
    Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
    Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The artificial pancreas: is it important to understand how the β cell controls blood glucose?
    Steil GM; Grodsky GM
    J Diabetes Sci Technol; 2013 Sep; 7(5):1359-69. PubMed ID: 24124965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.
    Holterhus PM; Bokelmann J; Riepe F; Heidtmann B; Wagner V; Rami-Merhar B; Kapellen T; Raile K; Quester W; Holl RW;
    Diabetes Care; 2013 Jun; 36(6):1507-11. PubMed ID: 23404300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
    Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
    Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.
    Girardot S; Jacquemier P; Mousin F; Rendekeu C; Hardy S; Riveline JP
    Diabetes Technol Ther; 2020 Jun; 22(6):476-483. PubMed ID: 32069066
    [No Abstract]   [Full Text] [Related]  

  • 50. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results.
    Kanderian SS; Weinzimer SA; Steil GM
    J Diabetes Sci Technol; 2012 Mar; 6(2):371-9. PubMed ID: 22538149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control-relevant models for glucose control using a priori patient characteristics.
    van Heusden K; Dassau E; Zisser HC; Seborg DE; Doyle FJ
    IEEE Trans Biomed Eng; 2012 Jul; 59(7):1839-49. PubMed ID: 22127988
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.